Dakota Wealth Management Bio Rad Laboratories, Inc. Transaction History

Dakota Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$350.25 - $422.63 $2,451 - $2,958	-7 Reduced 0.54%	1,281 $459,000
Q2 2023 Jul 31, 2023	SELL	$359.49 - $486.4 $21,209 - $28,697	-59 Reduced 4.38%	1,288 $488,000
Q1 2023 Apr 14, 2023	BUY	$418.69 - $503.0 $29,308 - $35,210	70 Added 5.48%	1,347 $645,000
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $76,321 - $98,954	217 Added 20.47%	1,277 $537,000
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $111,399 - $152,080	270 Added 34.18%	1,060 $443,000
Q2 2022 Aug 05, 2022	BUY	$463.67 - $597.16 $366,299 - $471,756	790 New	790 $391,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Dakota Wealth Management with notifications on news.